Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows revision v3.6.6, replacing the previous v3.6.5, indicating a minor administrative update to the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe page displays a new revision stamp (v3.6.5) replacing the previous v3.6.4, indicating a minor update to the page's metadata. No substantive study content appears to be changed.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page shows a new Revision: v3.6.4 in place of the previous v3.6.3, indicating a software release or patch applied to the page. This is a maintenance update rather than a substantive modification to the study data.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor update to the page build; the visible study details appear unchanged.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page’s revision tag has been updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This reflects an update to the page’s documentation/versioning rather than a change to trial data or study details.SummaryDifference0.1%

- Check90 days agoChange DetectedNew navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added and the page revision updated to Revision: v3.6.0. The personnel attribution was adjusted, with Shen Lin appearing as a contributor and the Shen Lin, Peking University line removed.SummaryDifference2%

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.